Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$46.8 million.

  • Cross Country Healthcare's Cash from Financing Activities rose 9994.97% to -$6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.2 million, marking a year-over-year increase of 8080.96%. This contributed to the annual value of -$46.8 million for FY2024, which is 7882.44% up from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Cash from Financing Activities is -$46.8 million, which was up 7882.44% from -$221.2 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Cash from Financing Activities registered a high of $119.1 million during FY2021, and its lowest value of -$221.2 million during FY2023.
  • Its 5-year average for Cash from Financing Activities is -$51.7 million, with a median of -$46.8 million in 2024.
  • Per our database at Business Quant, Cross Country Healthcare's Cash from Financing Activities soared by 64109.04% in 2021 and then plummeted by 17355.45% in 2022.
  • Annual analysis of 5 years shows Cross Country Healthcare's Cash from Financing Activities stood at -$22.0 million in 2020, then skyrocketed by 641.09% to $119.1 million in 2021, then plummeted by 173.55% to -$87.6 million in 2022, then crashed by 152.56% to -$221.2 million in 2023, then surged by 78.82% to -$46.8 million in 2024.
  • Its last three reported values are -$46.8 million in FY2024, -$221.2 million for FY2023, and -$87.6 million during FY2022.